CAPTRUST Financial Advisors
GMED icon

CAPTRUST Financial Advisors’s Globus Medical GMED Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Sell
25,072
-4,147
-14% -$352K ﹤0.01% 1302
2026
Q1 		$2.52M Buy
29,219
+3,420
+13% +$307K ﹤0.01% 1097
2025
Q4 		$2.25M Sell
25,799
-831
-3% -$63.1K ﹤0.01% 1043
2025
Q3 		$1.53M Buy
26,630
+2,297
+9% +$132K ﹤0.01% 1180
2025
Q2 		$1.44M Buy
24,333
+2,112
+10% +$136K ﹤0.01% 1143
2025
Q1 		$1.63M Sell
22,221
-1,514
-6% -$125K ﹤0.01% 1008
2024
Q4 		$1.96M Buy
23,735
+3,215
+16% +$254K 0.01% 892
2024
Q3 		$1.47M Sell
20,520
-3,681
-15% -$260K ﹤0.01% 984
2024
Q2 		$1.66M Buy
24,201
+1,231
+5% +$73.5K 0.01% 900
2024
Q1 		$1.23M Buy
22,970
+2,831
+14% +$152K ﹤0.01% 1017
2023
Q4 		$1.07M Sell
20,139
-13,186
-40% -$643K ﹤0.01% 1212
2023
Q3 		$1.65M Buy
33,325
+5,493
+20% +$307K 0.01% 937
2023
Q2 		$1.66M Sell
27,832
-78
-0.3% -$4.45K 0.01% 908
2023
Q1 		$1.58M Sell
27,910
-90
-0.3% -$5.77K 0.01% 827
2022
Q4 		$2.08M Sell
28,000
-776
-3% -$52.8K 0.01% 707
2022
Q3 		$1.71M Buy
28,776
+227
+0.8% +$13.7K 0.01% 725
2022
Q2 		$1.6M Buy
28,549
+74
+0.3% +$4.86K 0.01% 665
2022
Q1 		$2.1M Sell
28,475
-1,381
-5% -$96K 0.01% 587
2021
Q4 		$2.16M Buy
29,856
+36
+0.1% +$2.61K 0.01% 543
2021
Q3 		$2.29M Buy
29,820
+305
+1% +$24.5K 0.02% 495
2021
Q2 		$2.29M Sell
29,515
-687
-2% -$48.8K 0.02% 465
2021
Q1 		$1.86M Buy
30,202
+2,694
+10% +$171K 0.02% 488
2020
Q4 		$1.79M Sell
27,508
-8,004
-23% -$460K 0.02% 433
2020
Q3 		$1.74M Buy
35,512
+1,218
+4% +$62.8K 0.03% 370
2020
Q2 		$1.67M Buy
34,294
+21,230
+163% +$1.02M 0.03% 384
2020
Q1 		$522K Buy
13,064
+5,874
+82% +$290K 0.01% 583
2019
Q4 		$427K Buy
+7,190
New +$390K 0.01% 731
2018
Q2 		– Sell
-60
Closed -$3K – 1548
2018
Q1 		$3K Buy
+60
New +$2.82K ﹤0.01% 1203

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CAPTRUST Financial Advisors's GMED Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Globus Medical (GMED) stake by 14% in Q2 2026, selling an estimated $352K and leaving 25,072 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #1302.

CAPTRUST Financial Advisors first reported a position in GMED in Q1 2018 and has held it in 28 quarters since. The position peaked at $2.52M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • CAPTRUST Financial Advisors held 25,072 shares of Globus Medical worth $1.98M as of Q2 2026.
  • CAPTRUST Financial Advisors sold 4,147 Globus Medical shares in Q2 2026, an estimated $352K.
  • Globus Medical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1302 holding.
  • CAPTRUST Financial Advisors first reported a position in Globus Medical in Q1 2018 and has held it in 28 quarters since.
  • CAPTRUST Financial Advisors's Globus Medical position peaked at $2.52M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.